CPB evokes an inflammatory response marked by inflammatory mediators such as interleukine-6, interleukine-1β and tumor necrosis factor α, that are associated with blood–brain barrier disruption and neuroinflammation, leading to neuronal damage and cognitive impairment [14,27,28,29,30]. The gene discussed is IL6; the disease is Cognitive impairment.